Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid
- PMID: 15231727
- DOI: 10.1096/fj.04-1890fje
Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid
Abstract
Alzheimer's disease (AD) is characterized by the presence of neurofibrillary tangles and amyloid plaques, which are abnormal protein deposits. The major constituent of the plaques is the neurotoxic beta-amyloid peptide (Abeta); the genetics of familial AD support a direct role for this peptide in AD. Abeta neurotoxicity is linked to hydrogen peroxide formation. Abeta coordinates the redox active transition metals, copper and iron, to catalytically generate reactive oxygen species. The chemical mechanism underlying this process is not well defined. With the use of density functional theory calculations to delineate the chemical mechanisms that drive the catalytic production of H2O2 by Abeta/Cu, tyrosine10 (Y10) was identified as a pivotal residue for this reaction to proceed. The relative stability of tyrosyl radicals facilitates the electron transfers that are required to drive the reaction. Confirming the theoretical results, mutation of the tyrosine residue to alanine inhibited H2O2 production, Cu-induced radicalization, dityrosine cross-linking, and neurotoxicity.
Similar articles
-
The redox chemistry of the Alzheimer's disease amyloid beta peptide.Biochim Biophys Acta. 2007 Aug;1768(8):1976-90. doi: 10.1016/j.bbamem.2007.02.002. Epub 2007 Feb 9. Biochim Biophys Acta. 2007. PMID: 17433250 Review.
-
Dimerisation of N-acetyl-L-tyrosine ethyl ester and Abeta peptides via formation of dityrosine.Free Radic Res. 2006 Jan;40(1):1-9. doi: 10.1080/10715760500329721. Free Radic Res. 2006. PMID: 16298754
-
Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.Biochemistry. 2004 Jan 20;43(2):560-8. doi: 10.1021/bi0358824. Biochemistry. 2004. PMID: 14717612
-
Identifying, by first-principles simulations, Cu[amyloid-β] species making Fenton-type reactions in Alzheimer's disease.J Phys Chem B. 2013 Dec 27;117(51):16455-67. doi: 10.1021/jp410046w. Epub 2013 Dec 13. J Phys Chem B. 2013. PMID: 24313818
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
Cited by
-
From omics to drug metabolism and high content screen of natural product in zebrafish: a new model for discovery of neuroactive compound.Evid Based Complement Alternat Med. 2012;2012:605303. doi: 10.1155/2012/605303. Epub 2012 Aug 5. Evid Based Complement Alternat Med. 2012. PMID: 22919414 Free PMC article.
-
Amyloid-beta (Aβ) D7H mutation increases oligomeric Aβ42 and alters properties of Aβ-zinc/copper assemblies.PLoS One. 2012;7(4):e35807. doi: 10.1371/journal.pone.0035807. Epub 2012 Apr 30. PLoS One. 2012. PMID: 22558227 Free PMC article.
-
Deregulation of subcellular biometal homeostasis through loss of the metal transporter, Zip7, in a childhood neurodegenerative disorder.Acta Neuropathol Commun. 2014 Feb 28;2:25. doi: 10.1186/2051-5960-2-25. Acta Neuropathol Commun. 2014. PMID: 24581221 Free PMC article.
-
Applications of electron paramagnetic resonance to studies of neurological disease.Eur Biophys J. 2008 Mar;37(3):281-94. doi: 10.1007/s00249-008-0261-8. Epub 2008 Feb 7. Eur Biophys J. 2008. PMID: 18256819 Review.
-
Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation.Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):381-6. doi: 10.1073/pnas.0809057106. Epub 2009 Jan 2. Proc Natl Acad Sci U S A. 2009. PMID: 19122148 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical